Actuate Therapeutics ACTU
NASDAQ ACTU
$0.33 +0.03 (+11.08%)
As of: Nov 11, 2026 · 9:36 AM EST

Actuate Therapeutics (ACTU) Net Equity Issued and Repurchased (2024 - 2026)

Updated

Actuate Therapeutics (ACTU) recorded Net Equity Issued and Repurchased of $4.59 million in FY2025, down 80.8% from $23.96 million in FY2024.

Analysis

Actuate Therapeutics (ACTU) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

  • Per Business Quant data, ACTU's Net Equity Issued and Repurchased was $23.96 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Actuate Therapeutics 7.20 Mn -35.44 Mn - 731,589.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 731,589.00
Mar 31, 2026 519,624.00
Sep 30, 2025 1.63 Mn
Jun 30, 2025 6.82 Mn
Dec 31, 2024 -109,412.00
Sep 30, 2024 23.96 Mn
API Access

Actuate Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ACTU&period=max&api_key=YOUR_API_KEY